UK News Archive

The UK News Archive contains resources intended for journalists only.

2021

June

Media Release / Jun 17, 2021

Novartis Cosentyx® (secukinumab) recommended by NICE for adults with non-radiographic axial spondyloarthritis (nr-axSpA)

Read More
Media Release / Jun 04, 2021

Novartis continues to push the boundaries of innovation, reimagining medicine, with bold science as it today unveils strong presence at ASCO, including overall survival data in prostate and breast cancer

Read More

April

Media Release / Apr 21, 2021

NICE recommends Novartis’ Kesimpta®▼ (ofatumumab) for patients living with relapsing remitting multiple sclerosis (RRMS)

Read More
Media Release / Apr 21, 2021

Industry leaders launch HealthHub 21 to scale-up digital solutions for faster & more accessible care

Read More
Media Release / Apr 07, 2021

Novartis receives European and UK licence for Kesimpta® ▼ (ofatumumab), the first self-administered B-cell therapy for patients with relapsing forms of MS

Read More
Media Release / Apr 06, 2021

Novartis UK updated statement on Estradot Stock

Read More

March

Media Release / Mar 31, 2021

Novartis launches ‘See What’s Next’, a disease awareness campaign to support people with wet AMD to remain independent for longer

Read More
Media Release / Mar 26, 2021

Novartis UK and Cievert announce digital innovation partnership to support the NHS in its recovery

Read More
Media Release / Mar 08, 2021

Novartis UK updated statement on Estradot stock

Read More
Media Release / Mar 08, 2021

Landmark agreement enables families in England to have access to innovative one-time gene therapy on the NHS

Read More

Related Links